Author:
Truong Daniel D., ,Gollomp Stephen M.,Jankovic Joseph,LeWitt Peter A.,Marx Michael,Hanschmann Angelika,Fernandez Hubert H.
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology
Reference24 articles.
1. Allergan, Inc. (2011) Botox® US Prescribing Information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103000s5232lbl.pdf . Accessed 18 June 2012
2. Benecke R, Jost WH, Kañovský P, Ruzicka E, Comes G, Grafe S (2005) A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 64:1949–1951
3. Comella CL, Jankovic J, Truong DD, Hanschmann A, Grafe S (2011) Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. J Neurol Sci 308:103–109
4. Daly K (1997) Blepharospasm: an Australian survey. Int J Rehabil Res 20:41–50
5. Frevert J (2009) Xeomin is free from complexing proteins. Toxicon 54:697–701
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献